Your session is about to expire
← Back to Search
Protamine fixed dose for Intravascular Coagulation
Study Summary
This trial will compare two different protamine doses to see which is more effective.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are physicians actively seeking out participants for this experiment?
"Affirmative. Per the data on clinicaltrials.gov, this trial is presently seeking participants to enroll; it was inaugurated on 28th June 2022 and has been revised at least once since then (28th July). 130 volunteers are required from two sites of recruitment."
How efficacious is Protamine fixed dose in safeguarding individuals?
"There is significant evidence backing the use of Protamine fixed dose, which earns it a rating of 3. This Phase 4 treatment has already been approved by regulatory bodies."
What is the current participant capacity for this research project?
"Affirmative. Clinicaltrials.gov reveals that the investigation is currently enrolling participants, which began on June 28th 2022 and was recently amended on July 28th 2022. This research requires 130 patients to be recruited from 2 sites."
Share this study with friends
Copy Link
Messenger